Log in to save to my catalogue

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results fro...

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results fro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2057870517

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

A total of 156 patients (age range 1.3–18.0 years, median 13.2 years; 91 (58.3%) male) with newly diagnosed CML (
N
 = 146 chronic phase (CML-CP),
N
 = 3 accelerated phase (CML-AP),
N
 = 7 blastic phase (CML-BP)) received imatinib up-front (300, 400, 500 mg/m
2
, respectively) within a prospective phase III trial. Therapy re...

Alternative Titles

Full title

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2057870517

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2057870517

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-018-0179-9

How to access this item